Bremer Bank National Association Gilead Sciences, Inc. Transaction History

Bremer Bank National Association

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 07, 2022	SELL	$57.92 - $72.58 $183,316 - $229,715	-3,165 Closed	0 $0
Q4 2021 Jan 10, 2022	BUY	$64.88 - $73.64 $2,141 - $2,430	33 Added 1.05%	3,165 $230,000
Q3 2021 Oct 05, 2021	SELL	$67.69 - $73.03 $8,528 - $9,201	-126 Reduced 3.87%	3,132 $219,000
Q2 2021 Jul 13, 2021	BUY	$63.47 - $69.35 $206,785 - $225,942	3,258 New	3,258 $224,000
Q2 2019 Aug 13, 2019	SELL	$61.87 - $69.38 $158,077 - $177,265	-2,555 Closed	0 $0
Q1 2019 May 09, 2019	BUY	$62.53 - $70.05 $159,764 - $178,977	2,555 New	2,555 $166,000

1,923

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $111B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Bremer Bank National Association, based on Form 13F filings with the SEC.

Stay updated on Bremer Bank National Association with notifications on news.